Evaluation for topical use of ripasudil as ophthalmic solution.

Evaluation for topical use of ripasudil as ophthalmic solution. - Evaluation for topical use of ripasudil as ophthalmic solution.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046037

Enrollment

Registered

2021-11-11

Start date

2019-11-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Without active ocular surface disease

Exclusion criteria

Exclusion criteria: With active ocular surface disease

Design outcomes

Primary

Measure	Time frame
visual acuity, IOP, ECD, CCT, TCT	—

Countries

Japan

Contacts

Public ContactHisataka Fujimoto

Kawasaki Medical School Department of Ophthalmology

fujimoto-h@med.kawasaki-m.ac.jp0864621111

Outcome results